Inactive Instrument

ALPA HEAL Stock

Equities

AHAC

US0207511033

Dynamic Chart
Alpha Healthcare Acquisition Corp.(NasdaqCM:AHAC) dropped from NASDAQ Composite Index CI
Humacyte, Inc. completed the acquisition of Alpha Healthcare Acquisition Corp. from a group of shareholders in a reverse merger transaction. CI
Alpha Healthcare Acquisition : Receives Shareholder Approval for Humacyte Deal MT
Alpha Healthcare Acquisition Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
ALPHA HEALTHCARE ACQUISITION : Benchmark Capital Starts Alpha Healthcare Acquisition at Buy with $18 Price Target MT
Alpha Healthcare Acquisition : Humacyte Names Dale Sander as CFO MT
Alpha Healthcare Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
ALPHA HEALTHCARE ACQUISITION : Lake Street Starts Alpha Healthcare Acquisition at Buy with $20 Price Target MT
Certain Class B Common Stock of Alpha Healthcare Acquisition Corp. are subject to a Lock-Up Agreement Ending on 16-MAR-2021. CI
Alpha Healthcare Acquisition : to Combine With Humacyte MT
Humacyte, Inc. entered into a non-binding term sheet to acquire Alpha Healthcare Acquisition Corp. from a group of shareholders in a reverse merger transaction for approximately $990 million. CI
Alpha Healthcare Acquisition Corp.(NasdaqCM:AHAC) added to NASDAQ Composite Index CI
Alpha Healthcare Acquisition Corp. has completed an IPO in the amount of $100 million. CI
Alpha Healthcare Acquisition Corp. has filed an IPO in the amount of $100 million. CI
More news
Alpha Healthcare Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It intends to source, acquire and manage a business in the healthcare industry in the United States. It has not commenced any operations.
Sector
-
More about the company